BioVie Stockholders Approve Key Proposals at Annual Meeting
BioVie Inc. held its annual stockholders' meeting on November 10, 2025, where key proposals were approved, including the election of directors, the appointment of EisnerAmper LLP as auditors, and an amendment to increase shares in the 2019 Omnibus Equity Incentive Plan. Analysts rate BIVI stock as a Buy with a $12.00 target, but Spark's AI Analyst indicates an Underperform rating due to financial challenges, high cash burn, and bearish technical indicators. BioVie currently has a market cap of $11.75M and an average trading volume of 216,774.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
BioVie ( (BIVI) ) just unveiled an update.
On November 10, 2025, BioVie Inc. held its annual meeting of stockholders, where several key proposals were considered. Stockholders elected the company’s nominees for director for one-year terms, ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026, and approved an amendment to the 2019 Omnibus Equity Incentive Plan to increase the number of shares authorized for issuance.
The most recent analyst rating on (BIVI) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on BioVie stock, see the BIVI Stock Forecast page.
Spark’s Take on BIVI Stock
According to Spark, TipRanks’ AI Analyst, BIVI is a Underperform.
BioVie faces significant financial challenges as it remains in the R&D phase with no revenue. The strong equity position offers some balance sheet support, but high cash burn and reliance on external financing are concerns. Technical indicators show bearish momentum, and valuation metrics reflect typical pre-revenue biotech risks. Overall, the stock is rated poorly due to these combined factors.
To see Spark’s full report on BIVI stock, click here.
More about BioVie
Average Trading Volume: 216,774
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.75M
